A detailed history of Pictet & Cie (Europe) Sa transactions in Danaher Corp stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 157,001 shares of DHR stock, worth $35.9 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
157,001
Previous 232,651 32.52%
Holding current value
$35.9 Million
Previous $58.1 Million 24.92%
% of portfolio
1.04%
Previous 1.42%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$239.25 - $280.76 $18.1 Million - $21.2 Million
-75,650 Reduced 32.52%
157,001 $43.6 Million
Q2 2024

Jul 25, 2024

SELL
$235.51 - $267.98 $25 Million - $28.5 Million
-106,304 Reduced 31.36%
232,651 $58.1 Million
Q1 2024

May 07, 2024

BUY
$224.58 - $256.19 $16.1 Million - $18.3 Million
71,608 Added 26.78%
338,955 $84.6 Million
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $3.23 Million - $4.07 Million
17,440 Added 6.98%
267,347 $61.8 Million
Q3 2023

Nov 02, 2023

SELL
$233.08 - $265.59 $5.57 Million - $6.35 Million
-23,906 Reduced 8.73%
249,907 $62 Million
Q2 2023

Aug 08, 2023

BUY
$224.99 - $256.14 $2.15 Million - $2.45 Million
9,548 Added 3.61%
273,813 $65.7 Million
Q1 2023

May 01, 2023

SELL
$239.75 - $277.0 $2.32 Million - $2.68 Million
-9,684 Reduced 3.53%
264,265 $66.6 Million
Q4 2022

Feb 08, 2023

SELL
$241.42 - $282.29 $987,890 - $1.16 Million
-4,092 Reduced 1.47%
273,949 $0
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $305,366 - $1.86 Million
-1,236 Reduced 0.44%
278,041 $71.8 Billion
Q2 2022

Aug 05, 2022

BUY
$237.11 - $299.66 $513,580 - $649,063
2,166 Added 0.78%
279,277 $70.8 Million
Q1 2022

May 04, 2022

BUY
$257.27 - $315.76 $13.3 Million - $16.3 Million
51,531 Added 22.84%
277,111 $81.3 Million
Q4 2021

Feb 02, 2022

SELL
$292.08 - $329.01 $693,105 - $780,740
-2,373 Reduced 1.04%
225,580 $74.2 Million
Q3 2021

Nov 10, 2021

BUY
$272.21 - $332.43 $276,293 - $337,416
1,015 Added 0.45%
227,953 $69.4 Million
Q2 2021

Aug 11, 2021

SELL
$225.08 - $271.69 $163,183 - $196,975
-725 Reduced 0.32%
226,938 $60.9 Million
Q1 2021

May 10, 2021

BUY
$212.38 - $245.9 $2.85 Million - $3.3 Million
13,416 Added 6.26%
227,663 $51.2 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $3.99 Million - $4.61 Million
-18,793 Reduced 8.06%
214,247 $47.6 Million
Q3 2020

Nov 10, 2020

BUY
$177.16 - $215.33 $1.84 Million - $2.24 Million
10,400 Added 4.67%
233,040 $50.2 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $2.47 Million - $3.39 Million
19,185 Added 9.43%
222,640 $39.4 Million
Q1 2020

Apr 30, 2020

BUY
$121.39 - $169.05 $19 Million - $26.5 Million
156,708 Added 335.23%
203,455 $28.2 Million
Q4 2019

Jan 31, 2020

BUY
$133.47 - $153.48 $1.68 Million - $1.93 Million
12,551 Added 36.7%
46,747 $7.18 Million
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $212,442 - $229,811
1,569 Added 4.81%
34,196 $4.94 Million
Q2 2019

Aug 07, 2019

BUY
$124.88 - $143.73 $56,695 - $65,253
454 Added 1.41%
32,627 $4.66 Million
Q1 2019

May 01, 2019

SELL
$97.62 - $132.29 $2.73 Million - $3.7 Million
-27,939 Reduced 46.48%
32,173 $4.25 Million
Q4 2018

Jan 31, 2019

SELL
$94.85 - $109.54 $1.01 Million - $1.16 Million
-10,598 Reduced 14.99%
60,112 $6.2 Million
Q3 2018

Nov 07, 2018

BUY
$98.13 - $108.9 $113,242 - $125,670
1,154 Added 1.66%
70,710 $7.68 Million
Q2 2018

Aug 10, 2018

SELL
$96.1 - $103.24 $179,226 - $192,542
-1,865 Reduced 2.61%
69,556 $6.86 Million
Q1 2018

May 09, 2018

SELL
$92.16 - $103.8 $91,699 - $103,281
-995 Reduced 1.37%
71,421 $6.99 Million
Q4 2017

Feb 09, 2018

SELL
$85.26 - $94.62 $482,145 - $535,076
-5,655 Reduced 7.24%
72,416 $6.72 Million
Q3 2017

Nov 07, 2017

SELL
$79.29 - $88.45 $4.42 Million - $4.93 Million
-55,695 Reduced 41.64%
78,071 $6.7 Million
Q2 2017

Aug 09, 2017

BUY
N/A
133,766
133,766 $11.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.